Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03780517
Title Safety, Efficacy, and Tolerability of BOS172738 in Patients With Advanced Rearranged During Transfection (RET) Gene-Altered Tumors
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements Yes
Sponsors Boston Pharmaceuticals
Indications

Advanced Solid Tumor

lung non-small cell carcinoma

thyroid gland medullary carcinoma

Therapies

DS-5010

Age Groups: senior | adult
Covered Countries USA | FRA | ESP | BEL

Additional content available in CKB BOOST